| Literature DB >> 24858636 |
Abstract
The concept of metacognition in the context of schizophrenia has recently received increasing attention in clinical psychology and psychiatry. impaired metacognitive abilities in patients with schizophrenia have been associated with symptomatology, cognition, social functioning and quality of life. in this series of articles published as a Special issue of the israel Journal of Psychiatry, edited by Paul H. Lysaker and ilanit Hasson-Ohayon, several new possible ramifications of metacognition with regard to persistence of symptoms, treatment issues and early recognition of schizophrenia are presented, in addition to corroborations of previous findings relating to the aetiology of impaired metacognition and outcome measures. the present invited commentary focuses on potential implications for a more individualized therapeutic approach to schizophrenia, early detection of at-risk states, and ways to link metacognition with neuroscientific approaches.Entities:
Mesh:
Year: 2014 PMID: 24858636
Source DB: PubMed Journal: Isr J Psychiatry Relat Sci ISSN: 0333-7308 Impact factor: 0.481